Phase 3 Blood Stream Infection Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

Central Line Associated Blood Stream Infections (CLABSI)

CorMedix200 enrolled15 locationsNCT06822426

Completed

Phase 2Phase 3

Biopatch (trademark) or Kendall (trademark) AMD Foam Disc to reduce the incidence of Central-Line-Associated Blood Stream Infection: A pilot randomized controlled trial

Central catheter related blood stream infection

Royal Brisbane and Womens Hospital100 enrolled1 locationACTRN12615000883516